Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Frontiers in Endocrinology|January 26, 2023
Hypoxia signaling pathway: A central mediator in endocrine tumorsDeepika Watts, Mangesh T Jaykar, Nicole Bechmann, et al.
International Journal of Cancer|November 19, 2011
Overexpression of factor inhibiting HIF-1 enhances vessel maturation and tumor growth via platelet-derived growth factor-CAleksandar Kuzmanov, Ben Wielockx, Maryam Rezaei, et al.
Pflugers Archiv : European Journal of Physiology|February 26, 2017
Interaction of endothelial cells with macrophages-linking molecular and metabolic signalingJoanna Kalucka, Laura Bierhansl, Ben Wielockx, et al.
International Journal of Molecular Sciences|September 10, 2021
Hypoxia Pathway Proteins and Their Impact on the Blood VasculatureDiego Rodriguez, Deepika Watts, Diana Gaete, et al.
Pflugers Archiv : European Journal of Physiology|February 14, 2024
Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesisStephen Ariyeloye, Susanne Kämmerer, Erik Klapproth, et al.
Cancers|March 6, 2021
HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer-Potential Targets for Anti-Tumor Therapy?Diana Gaete, Diego Rodriguez, Deepika Watts, et al.
Cancer Biology & Therapy|February 23, 2012
HIF prolyl hydroxylase-2 inhibition diminishes tumor growth through matrix metalloproteinase-induced TGFβ activationAnne Klotzsche-von Ameln, Antje Muschter, Markus M Heimesaat, et al.
Stroke|August 31, 2012
Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemiaReiner Kunze, Wei Zhou, Roland Veltkamp, et al.
Novartis Foundation Symposium|February 28, 2008
HIF in vascular development and tumour angiogenesisGeorg Breier, Alexander H Licht, Anke Nicolaus, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2002
Hyporesponsiveness of SPRET/Ei mice to lethal shock induced by tumor necrosis factor and implications for a TNF-based antitumor therapyJan Staelens, Ben Wielockx, Leen Puimège, et al.
Pageof 10